このエントリーをはてなブックマークに追加


ID 68635
FullText URL
fulltext.pdf 9.57 MB
Author
Asaka, Yutaro Department of Cellular Physiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Masumoto, Toshio Division of Health Administration and Promotion, Department of Social Medicine, Faculty of Medicine, Tottori University
Uneda, Atsuhito Department of Neurosurgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Chin, Vanessa D. UMass Chan Medical School, UMass Memorial Medical Center
Otani, Yusuke Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School
Pena, Tirso Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School
Katayama, Haruyoshi Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Itano, Takuto Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Ando, Teruhiko Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Huang, Rongsheng Department of Trauma Orthopedics, The Second Hospital of Dalian Medical University
Fujimura, Atsushi Department of Cellular Physiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences ORCID Kaken ID researchmap
Abstract
Glioblastoma cells are known to regulate their cellular plasticity in response to their surrounding microenvironment, but it is not fully understood what factors contribute to the cells' changing plasticity. Here, we found that glioblastoma cells alter the expression level of adrenoreceptors depending on their differentiation stage. Catecholamines are abundant in the central nervous system, and we found that noradrenaline, in particular, enhances the stemness of glioblastoma cells and promotes the dedifferentiation potential of already differentiated glioblastoma cells. Antagonist and RNAi experiments revealed that signaling through alpha 1D-adrenoreceptor is important for noradrenaline action on glioblastoma cells. We also found that high alpha 1Dadrenoreceptor expression was associated with poor prognosis in patients with gliomas. These data suggest that glioblastoma cells increase the expression level of their own adrenoreceptors to alter the surrounding tumor microenvironment favorably for survival. We believe that our findings will contribute to the development of new therapeutic strategies for glioblastoma.
Keywords
Adrenoceptors
Glioma stem-like cells
Differentiated glioma cells
Noradrenaline
Cellular plasticity
Published Date
2025-07
Publication Title
The Journal of Physiological Sciences
Volume
volume75
Issue
issue2
Publisher
Elsevier
Start Page
100016
ISSN
1880-6546
NCID
AA12129145
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2025 The Authors.
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1016/j.jphyss.2025.100016
License
http://creativecommons.org/licenses/by/4.0/